35 - ACS Flashcards
Don’t use fibrinolytic therapy in ____
NSTEMI
Describe the urgent acute tx for UA/NSTEMI
need early, urgent coronary angiography followed by if possible, by revascularization with PCI or bypass surgery in all high risk patients
UA/NSTEMI:
What do you use for initial attempts at symptom relief
nitroglycerin
UA/NSTEMI:
What drug do you start ASAP in all patients without contraindications?
Beta blocker
UA/NSTEMI:
When are CCBs indicated?
used to control ongoing symptoms of ischemia in patients receiving max doses of BBs and nitrates
UA/NSTEMI:
Which type of CCBs should be used cautiously with BBs?
Non-DHPs (diltiazem, verapamil)
- they act more centrally and behave similar to BBs
- can cause LV dysfunction, severe bradycardia or increased AV nodal block
UA/NSTEMI:
What CCB should you avoid bc it can cause acute drop in BP and cause a stroke?
IR nifedipine
UA/NSTEMI:
Why are ACEi’s used?
they reduce mortality
UA/NSTEMI:
When should you initiate an ACEi?
within 24 hours of presentation
UA/NSTEMI:
What is the preferred heparin in those who don’t have significant renal dysfunction (i.e. CrCl > 30)
Enoxaparin
UA/NSTEMI:
What do you use if CrCl < 30?
UFH is appropriate
UA/NSTEMI:
How long is heparin used for?
usually used x 2-5 days
UA/NSTEMI:
Do you use heparin following successful PCI?
Not usually
UA/NSTEMI:
_____ is as effective as enoxaparin in patients with NSTEMI
fondaparinux (factor Xa inhibitor)
UA/NSTEMI:
When would you consider bivalrudin (direct thrombin inhibitor)?
Bivalrudin use is considered a reasonable strategy in patients with ACS undergoing PCI with concomitant P2Y12 inhibition and/or GP2b/3a inhibitor use
UA/NSTEMI:
Give ____ indefinitely as part of antiplatelet therapy
ASA